OTCMKTS:APNHY - Aspen Pharmacare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$11.17
▼ -1.07 (-8.74%)

This chart shows the closing price for APNHY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aspen Pharmacare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APNHY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APNHY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Aspen Pharmacare in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $11.17.

This chart shows the closing price for APNHY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Aspen Pharmacare. This rating has held steady since November 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/26/2021Jefferies Financial GroupUpgradeHold ➝ Buy
12/5/2019Jefferies Financial GroupDowngradeBuy ➝ Hold
3/14/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
(Data available from 6/22/2016 forward)
Aspen Pharmacare logo
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Read More

Today's Range

Now: $11.17
Low: $11.17
High: $11.17

50 Day Range

MA: $11.38
Low: $9.54
High: $12.24

52 Week Range

Now: $11.17
Low: $6.29
High: $12.25

Volume

105 shs

Average Volume

2,453 shs

Market Capitalization

$5.10 billion

P/E Ratio

13.62

Dividend Yield

N/A

Beta

1.5

Frequently Asked Questions

What sell-side analysts currently cover shares of Aspen Pharmacare?

The following sell-side analysts have issued research reports on Aspen Pharmacare in the last year: Jefferies Financial Group Inc., and Zacks Investment Research.
View the latest analyst ratings for APNHY.

What is the current price target for Aspen Pharmacare?

0 Wall Street analysts have set twelve-month price targets for Aspen Pharmacare in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Aspen Pharmacare in the next year.
View the latest price targets for APNHY.

What is the current consensus analyst rating for Aspen Pharmacare?

Aspen Pharmacare currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe APNHY will outperform the market and that investors should add to their positions of Aspen Pharmacare.
View the latest ratings for APNHY.

What other companies compete with Aspen Pharmacare?

How do I contact Aspen Pharmacare's investor relations team?

Aspen Pharmacare's physical mailing address is 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge, Durban T3, 4051. The company's listed phone number is 27-31-580-8600. The official website for Aspen Pharmacare is www.aspenpharma.com.